Attached files
file | filename |
---|---|
EX-32.2 - ProPhase Labs, Inc. | ex32-2.htm |
EX-32.1 - ProPhase Labs, Inc. | ex32-1.htm |
EX-31.2 - ProPhase Labs, Inc. | ex31-2.htm |
EX-31.1 - ProPhase Labs, Inc. | ex31-1.htm |
EX-23.1 - ProPhase Labs, Inc. | ex23-1.htm |
EX-4.3 - ProPhase Labs, Inc. | ex4-3.htm |
10-K - ProPhase Labs, Inc. | form10-k.htm |
EXHIBIT 21.1
SUBSIDIARIES OF PROPHASE LABS, INC.
State or other | ||||
Jurisdiction of | Ownership | |||
Subsidiaries | Incorporation | Percentage | ||
Pharmaloz Manufacturing Inc. | Delaware | 100 % | ||
Phusion Labs Manufacturing, Inc. | Delaware | 100 % | ||
ProPhase Digital Media, Inc. | Delaware | 100 % | ||
Quigley Pharma Inc. | Delaware | 100 % | ||
TK Supplements, Inc. | Delaware | 100 % |
The above subsidiaries are included in the consolidated financial statements for the year ended December 31, 2019.